Increased lipoprotein(a) levels are not a steady prothrombotic defect [8]

Blood

Volumn 98, Issue 6, 2001, Pages 1993-1994

  Korte, Wolfgang ^a   Greiner, Jeanette ^a   Feldges, Andreas ^a   Riesen, Walter F ^a  

^a Kantonsspitat   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; INTERLEUKIN 6; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALBUMIN BLOOD LEVEL; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EFFECT; HUMAN; HYPERLIPOPROTEINEMIA; LETTER; LIPOPROTEIN BLOOD LEVEL; LYMPHOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; THROMBOEMBOLISM; THYROID FUNCTION; VEIN THROMBOSIS;

EID: 0035885954     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.6.1993     Document Type: Letter

References (14)

1. Nowak-Göttl U, Junker R, Kreuz W, et al. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood. 2001;97:858-862.
2. Nowak-Göttl U, Wermes C, Junker R, et al. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors. Blood. 1999;93:1595-1599.
3. Halton JM, Nazir DJ, McQueen MJ, Barr RD. Blood lipid profiles in children with acute lymphoblastic leukemia. Cancer. 1998;83:379-384.
4. Yang WS, Min WK, Park JS, Kim SB. Effect of increasing serum albumin on serum lipoprotein(a) concentration in patients receiving CAPD. Am J Kidney Dis. 1997;30:507-513.
5. de Bruin TW, van Barlingen H, van Linde-Sibenius Trip M, van Vuurst de Vries AR, Akveld MJ, Erkelens DW. Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects. J Clin Endocrinol Metab. 1993;76:121-126.
6. Engler H, Riesen WF. Effect of thyroid function on concentrations of lipoprotein(a). Clin Chem. 1993;39:2466-2469.
7. Lee YH, Choi SJ, Ji JD, Seo HS, Song GG. Lipoprotein(a) and lipids in relation to inflammation in rheumatoid arthritis. Clin Rheumatol. 2000;19:324-325.
8. Kario K, Matsuo T, Kobayashi H, Matsuo M, Asada R, Koide M. High lipoprotein (a) levels in chronic hemodialysis patients are closely related to the acute phase reaction. Thromb Haemost. 1995;74:1020-1024.
9. Gurbuz O, Ozdemir Y, Cosar CB, Kural G. Lipoprotein (a) in Behcet's disease as an indicator of disease activity and in thrombotic complications. Eur J Ophthalmol. 2001;11:62-65.
10. Noma A, Abe A, Maeda S, Seishima M, Makino K, Yano Y, Shimokawa K, Lp(a): an acute-phase reactant? Chem Phys Lipids. 1994;67-68:411-417.
11. Andreassen AK, Berg K, Torsvik H. Changes in Lp(a) lipoprotein and other plasma proteins during acute myocardial infarction. Clin Genet. 1994;46:410-416.
12. Mooser V, Berger MM, Tappy L, Cayeux C, Marcovina SM, Darioli R, Nicod P, Chiolero R. Major reduction in plasma Lp(a) levels during sepsis and burns. Arterioscler Thromb Vasc Biol. 2000;20:1137-1142.
13. Ramharack R, Barkalow D, Spahr MA. Dominant negative effect of TGF-beta1 and TNF-alpha on basal and IL-6-induced lipoprotein(a) and apolipoprotein(a) mRNA expression in primary monkey hepatocyte cultures. Arterioscler Thromb Vasc Biol. 1998;18:984-990.
14. Lippi G, Bassi A, Brocco G, Manzato F, Marini M, Guidi G. Lipoprotein(a) concentration is not associated with venous thromboembolism in a case control study. Haematologica. 1999;84:726-729.